q&more
My watch list
my.chemie.de  
Login  

Author

Dr. Carsten Marr

Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH

© HMGU

Dr. Carsten Marr

Carsten Marr, born in 1977, received his diploma in general physics from the Technische Universität München in 2002. He wrote his diploma thesis at the Max-Planck-Institute for Quantum Optics, Garching, Germany, and in 2003 visited the Quantum Information and Quantum Optics Theory Group at Imperial College London. In 2004, he received a PhD fellowship from the Technische Universität Darmstadt and joined the Bioinformatics Group there, working on dynamical processes on graphs and biological networks. He visited the Center for Complex Systems and Brain Sciences, Florida Atlantic University, USA, and Jacobs University Bremen, Germany during his PhD. After receiving his PhD from Technische Universität Darmstadt in 2007 he joined Jacobs University Bremen as a postdoctoral fellow, focusing on gene regulatory networks. In 2008 he joined the Helmholtz Zentrum München as a PostDoc in the Institute for Bioinformatics and Systems Biology, working on the quantification, analysis and modelling of stem cell data. In 2011, he worked on pluripotency and stochastic descriptions of gene expression at the University of Edinburgh with a stipend from the German Research Foundation (DFG). Since 2013, he has been deputy director and group leader at the Institute of Computational Biology.

Awards

In 2017, Marr received the Erwin-Schrödinger Prize and the CSB2 Prize in Systems Biology for his interdisciplinary contributions to the quantification of single blood stem cells. In 2019, he received an ERC Consolidator Grant for establishing Computational Hematopathology.

Focus

Marr’s research focuses on the application of computational methods to understand cellular decision making in health and disease.

Methods

  • Mechanistic mathematical models to fit biomedical data and predict stem cell kinetics
  • Deep learning algorithms to improve single cell profiling and image-based diagnostics

Facts, background information, dossiers

  • bioinformatics
  • systems biology
  • gene regulatory networks
  • blood stem cells
  • computational hemat…
  • deep learning
  • image-based diagnostics

Other articles by this author

All articles

More about Helmholtz Zentrum München

  • News

    The oat genome unlocks the unique health benefits of oats

    Researchers have succeeded in sequencing and characterizing the entire genome of oat. Compared to other cereals and humans, the oat genome architecture is very complex. Scientists from Helmholtz Munich, Lund University and the ScanOats network finally elucidated at the genetic level why oat ... more

    A Speed Limit Could Be a Breakthrough for Stem Cell Therapy

    Replacing sick or damaged cells with healthy cells: this is a major goal of regenerative medicine. One of the most promising approaches is cellular reprogramming, whereby one cell type in our body converts to another cell type. Research carried out at Helmholtz Munich and Ludwig-Maximilians ... more

    COVID-19: Breakthrough infection can substitute for a third vaccine shot

    According to a new study led by Ulrike Protzer, a breakthrough infection after two vaccinations achieves the same protective effect as an additional booster vaccination. According to the study by Helmholtz Munich, LMU and TUM, the decisive factor for immunity is that the immune system has h ... more

  • q&more articles

    Using deep learning to better understand blood disorders

    For a long time, doctors have been diagnosing disorders of the body’s hematopoietic system using a light microscope. The analysis of individual blood cells is largely performed manually. Now, artificial intelligence can lend them a digital hand. more

  • Authors

    Dr. Christian Matek

    Christian Matek, born in 1986, received undergraduate degrees in both Physics and Medicine in Munich. He then moved to the UK and finished his DPhil in Theoretical Physics at Oxford University in 2014. Since 2017, his main research interest has been applying artificial intelligence and mach ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:

 

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE